Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  imiquimod
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0041-63, 2012-003112-31, NCT01926496

2.

Phase: Phase IV
Type: Health services research, Prevention, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL50621.068.14, 836031011, 2014-003691-23, NCT02281682

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 21 and over
Sponsor: Other
Protocol IDs: CIP#NMCSD.2014.0040, NCT02130323

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD11/06-S, NCT01720407

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: KLI293, NCT01861535

6.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 27 and over
Sponsor: NCI, Other
Protocol IDs: AMC-088, NCI-2013-02288, U01CA121947, NCT02059499

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: AMC-A01, NCI-2014-00636, U01CA121947, NCT02135419

8.

Phase: Phase III
Type: Health services research, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL50433.068.14, NCT02242929

9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: METC 13-2-031, NCT02329171

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: STML-701-0114, NCT02078648

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UbiVac DPV-001, R44CA121612, NCT01909752

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 100
Sponsor: Other
Protocol IDs: 20110462, NCT01803152

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 to 99
Sponsor: Other
Protocol IDs: 20120750, NCT01808820

14.

Phase: Phase I
Type: Treatment
Status: Active
Age: Over 1 year to less than 30 years
Sponsor: Other
Protocol IDs: 20130136, NCT01902771

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J0656 CDR0000617261, JHOC-J0656, NA_00002176, 2P50CA098252, 1R21CA123876, NCT00788164

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14-116B, NCT02234921

17.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ATZ-1068-KRA-20I, NCT02276300

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: NCI, Other
Protocol IDs: PRO12050422, R01CA174858, NCT01795313

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 48861, NCT02301494
New Search